v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities:      
Net income $ 379.0 $ 391.0 $ 269.0
Adjustment to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 295.0 280.0 276.0
Amortization of deferred financing costs and original issue discount 8.0 7.0 9.0
Debt extinguishment and refinancing-related costs 2.0 5.0 10.0
Deferred income taxes 45.0 (17.0) (8.0)
Realized and unrealized foreign exchange losses, net 31.0 11.0 21.0
Stock-based compensation 25.0 28.0 26.0
Impairment charges 1.0 0.0 15.0
Interest income on swaps designated as net investment hedges (13.0) (15.0) (10.0)
Other non-cash, net 3.0 9.0 22.0
Changes in operating assets and liabilities:      
Trade accounts and notes receivable 97.0 (7.0) (119.0)
Inventories 33.0 12.0 103.0
Prepaid expenses and other assets (129.0) (130.0) (71.0)
Accounts payable (77.0) (49.0) 9.0
Other accrued liabilities (64.0) 36.0 29.0
Other liabilities 13.0 15.0 (6.0)
Cash provided by operating activities 649.0 576.0 575.0
Investing activities:      
Acquisitions, net of cash acquired (48.0) (301.0) (106.0)
Purchase of property, plant and equipment (196.0) (140.0) (138.0)
Interest proceeds on swaps designated as net investment hedges 13.0 15.0 10.0
Settlement proceeds on swaps designated as net investment hedges 0.0 0.0 29.0
Payments for loans to customers (10.0) (22.0) (3.0)
Other investing activities, net 29.0 8.0 2.0
Cash used for investing activities (212.0) (440.0) (206.0)
Financing activities:      
Proceeds from short-term borrowings 0.0 0.0 9.0
Proceeds from long-term borrowings 0.0 333.0 697.0
Payments on short-term borrowings 0.0 (5.0) (50.0)
Payments on long-term borrowings (230.0) (420.0) (904.0)
Financing-related costs (1.0) (6.0) (17.0)
Net cash flows associated with stock-based awards (3.0)    
Net cash flows associated with stock-based awards   4.0 8.0
Purchases of common stock (165.0) (100.0) (50.0)
Deferred acquisition-related consideration (1.0) (6.0) (8.0)
Other financing activities, net (1.0) (1.0) 0.0
Cash used for financing activities (401.0) (201.0) (315.0)
Increase (decrease) in cash and cash equivalents 36.0 (65.0) 54.0
Effect of exchange rate changes on cash 28.0 (42.0) (6.0)
Cash at beginning of period 596.0 703.0 655.0
Cash at end of period 660.0 596.0 703.0
Cash at end of period reconciliation:      
Cash and cash equivalents 657.0 593.0 700.0
Restricted cash 3.0 3.0 3.0
Cash at end of period 660.0 596.0 703.0
Cash paid during the year for:      
Interest, net of amounts capitalized 172.0 198.0 213.0
Income taxes, net of refunds 107.0 131.0 97.0
Non-cash investing activities:      
Accrued capital expenditures $ 26.0 $ 18.0 $ 13.0

Source